The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Viking Therapeutics Inc shares valued at $715,850 were sold by SINGLETON J MATTHEW on Sep 20 ’24. At $69.50 per share, SINGLETON J MATTHEW sold 10,300 shares. The insider’s holdings dropped to 9,500 shares worth approximately $0.61 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Lian Brian sold 216,130 shares, netting a total of over 15,308,553 in proceeds. Following the sale of shares at $70.83 each, the insider now holds 2,304,927 shares.
Before that, Lian Brian had added 216,130 shares to its account. In a trade valued at $3,978,372, the Officer bought Viking Therapeutics Inc shares for $18.41 each.
As published in their initiating research note from JP Morgan on September 11, 2024, Viking Therapeutics Inc [VKTX] has been an Overweight and the price target has been revised to $80. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in late June. As of May 16, 2024, Raymond James has increased its “an Outperform” rating to a “Strong buy” for VKTX. Earlier on March 26, 2024, Oppenheimer resumed its rating. Their recommendation was “an Outperform” for VKTX stock.
Analyzing VKTX Stock Performance
During the last five days, there has been a surge of approximately 2.87%. Over the course of the year, Viking Therapeutics Inc shares have jumped approximately 244.49%. Shares of the company reached a 52-week high of $99.41 on 02/28/24 and a 52-week low of $17.23 on 01/03/24. A 50-day SMA is recorded $60.74, while a 200-day SMA reached $54.80. Nevertheless, trading volume fell to 1.94 million shares from 1.69 million shares the previous day.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 62.91, which, if violated, would cause prices to drop to 61.70. In the upper region, resistance lies at 65.85. The next price resistance is at 67.58. RSI (Relative Strength Index) is 53.07 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.77, which suggests the price will decrease in the coming days. Percent R is at 69.99%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
